Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States

Journal of Infectious Diseases

Volumn 212, Issue 8, 2015, Pages 1200-1208

  Arriola, Carmen S ^a,s   Anderson, Evan J ^b,c   Baumbach, Joan ^d   Bennett, Nancy ^e   Bohm, Susan ^g   Hill, Mary ^h   Lindegren, Mary Lou ⁱ   Lung, Krista ^j   Meek, James ^k   Mermel, Elizabeth ^l   Miller, Lisa ^m   Monroe, Maya L ⁿ   Morin, Craig ^o   Oni, Oluwakemi ^p   Reingold, Arthur ^q   Schaffner, William ⁱ   Thomas, Ann ^r   Zansky, Shelley M ^f   Finelli, Lyn ^a   Chaves, Sandra S ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^g MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^h Salt Lake City Fire Department (SLCFD)   (United States)

ⁱ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j OHIO DEPARTMENT OF HEALTH   (United States)

^k YALE UNIVERSITY   (United States)

^l RHODE ISLAND DEPARTMENT OF HEALTH   (United States)

^m Colorado Department of Public Health and Environment ^*  (United States)

ⁿ MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^o MINNESOTA DEPARTMENT OF HEALTH   (United States)

^p IOWA DEPARTMENT OF PUBLIC HEALTH   (United States)

^q CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^r OREGON PUBLIC HEALTH DIVISION   (United States)

^s NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

more..

Author keywords

adults; influenza; influenza vaccine; severe illness

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ANTIVIRAL THERAPY; BODY MASS; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INTENSIVE CARE UNIT; LENGTH OF STAY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SEASONAL INFLUENZA; SMOKING; UNITED STATES; AGED; FEMALE; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MORTALITY; SEASON; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VACCINATION;

INFLUENZA VACCINE;

AGED; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA; SEASONS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VACCINATION;

EID: 84943404098     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv200     Document Type: Review

References (49)

1. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012; 54: 1427-36
2. Thompson M, Shay D, Zhou H, et al. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010; 59: 1057-62
3. Centers for Disease Control and Prevention. Influenza activity-United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013; 62: 473-9
4. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179-86
5. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014; 58: 319-27
6. McLean HQ, Thompson MG, Sundaram ME, et al. Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015; 211: 1529-40
7. Flannery B, Thaker SN, Clippard J, et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 137-42
8. Kissling E, Valenciano M, Buchholz U, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season. 2012/13. Euro Surveill. 2014; 19: pii: 20701
9. Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-Adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014; 9: e92153
10. Castilla J, Godoy P, Dominguez A, et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013; 57: 167-75
11. Perez-Romero P, Aydillo TA, Perez-Ordonez A, et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect. 2012; 18: E533-40
12. Ridenhour BJ, Campitelli MA, Kwong JC, et al. Effectiveness of inactivated influenza vaccines in preventing influenza-Associated deaths and hospitalizations among Ontario residents aged /=65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One. 2013; 8: e76318
13. Aaby P, Bhuiya A, Nahar L, Knudsen K, de Francisco A, Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol. 2003; 32: 106-16
14. Preziosi MP, Halloran ME. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin Infect Dis. 2003; 37: 772-9
15. Vila-Corcoles A, Ochoa-Gondar O, Llor C, Hospital I, Rodriguez T, Gomez A. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. Eur Respir J. 2005; 26: 1086-91
16. Schnorr JJ, Cutts FT, Wheeler JG, et al. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine. 2001; 19: 1503-10
17. Chaves SS, Aragon D, Bennett N, et al. Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. J Infect Dis. 2013; 208: 1305-14
18. Treanor J. Influenza viruses, including avian influenza and swine influenza. In: MandellBennett GLJE, Dolin R, eds. Principles and practice of infectious diseases. Vol 2. Philadelphia: Churchill Livingstone, 2010: 2265-93
19. Enstone JE, Myles PR, Openshaw PJ, et al. Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis. 2011; 17: 592-8
20. Jhung MA, DMello T, Perez A, et al. Hospital-onset influenza hospitalizations-United States, 2010-2011. Am J Infect Control. 2014; 42: 7-11
21. Rosenbaum PR, Rubin DB. The bias due to incomplete matching. Biometrics. 1985; 41: 103-16
22. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996; 52: 249-64
23. Williamson EJ, Forbes A. Introduction to propensity scores. Respirology. 2014; 19: 625-35
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-83
25. McGregor JC, Kim PW, Perencevich EN, et al. Utility of the chronic disease score and charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol. 2005; 161: 483-93
26. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011; 173: 676-82
27. Burnham KP, Anderson DR. Model selection and multimodel inference 2nd ed. New York: Springer, 1998
28. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014; 371: 635-45
29. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis. 2009; 200: 172-80
30. van Essen GA, Beran J, Devaster JM, et al. Influenza symptoms and their impact on elderly adults: randomised trial of AS03-Adjuvanted or non-Adjuvanted inactivated trivalent seasonal influenza vaccines. Influenza Other Respir Viruses. 2014; 8: 452-62
31. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006; 35: 337-44
32. Simonsen L, Viboud C, Taylor RJ, Miller MA, Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine. 2009; 27: 6300-4
33. Gilca R, De Serres G, Boulianne N, et al. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses. 2011; 5: 247-55
34. McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine. 2014; 32: 453-7
35. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007; 357: 1373-81
36. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009; 170: 650-6
37. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007; 7: 658-66
38. Kumar A. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life. J Antimicrob Chemother. 2011; 66: 959-63
39. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007; 45: 1568-75
40. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-Analysis of individual participant data. Lancet Respir Med. 2014; 2: 395-404
41. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis. 2008; 197: 490-502
42. Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenzaassociated hospitalizations in older adults. Clin Infect Dis. 2014; 59: 406-9
43. Hiba V, Chowers M, Levi-Vinograd I, Rubinovitch B, Leibovici L, Paul M. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. J Antimicrob Chemother. 2011; 66: 1150-5
44. Chan MC, Lee N, Ngai KL, Leung TF, Chan PK. Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. J Clin Microbiol. 2014; 52: 497-501
45. Yu W, Ash AS, Levinsky NG, Moskowitz MA. Intensive care unit use and mortality in the elderly. J Gen Intern Med. 2000; 15: 97-102
46. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010; 28: 7381-8
47. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-Analysis. Ann Intern Med. 2012; 156: 500-11
48. Millman A, Reed C, Kirby P, et al. Impact of changes in diagnostic testing on estimated influenza-Associated hospitalization rates in the influenza hospitalization surveillance network (FluSurv-NET): United States, 2003-2013. In: Program and abstracts of the 63rd Annual Epidemic Intelligence Service Conference. Atlanta, GA: Centers for Disease Control and Prevention, 2014: 104
49. Viasus D, Pano-Pardo JR, Pachon J, et al. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection. Chest. 2011; 140: 1025-32